Page 1 - index

Brief Report on Field Trial with biostimulant Albit® liquid paste

Agricultural crop Sugar beet

Variety Annemaria. Rosalinda

Location of trial (farm, region, country) KWS Saat AG, Germany
Scientist in charge o f the trials Dr. R alf Tilcher
Date of sowing 20.03.2014 (field plot)

Date of harvesting 4 leaves stage (BBC H 14) - 12-13 days for laboratory experiment
or 23.04.2014 (field plot)

Number of treatments with Albit 1 (seed treatment)
Application rate of Albit 0.5 or 5.0 ml per sowing unit (U)

Standard KWS laboratory and plot seed evaluation technologies were used. Seeds in control were
treated with standard set of fertilizers.

Laboratory experiments

On sugarbeet var. Annemaria, seed treatment with Albit caused 7-fold increase of seed
germination at a dosage of 5 ml/U and 3-fold increase at a dosage of 0,5 mL/U over control (7%
and 3% germination on 4th day of experiment while 1% in control). On the 5th day. germination of
Albit-treated variants was 42-53% while 24% in control. On 6th day: 85-91% and 77% respectively.
Therefore. Albit had very positive effect on early emergency of sugarbeet seeds. Application of
Albit (5ml/U) without fertilizer improved lab emergency 2 times even if compared with a control
with fertilizer addition (fig. 1). So in this instance Albit acted as a substitute of fertilizer.
Seed driving power was enhanced in all variants treated with Albit on both sugarbeet
varieties tested: Annemaria (fig. 2.1) and Rosalinda (fig. 2.2).

Field experiment
In the field experiment Albit increased the germination of sugarbeet seeds var. Rosalinda —
up to 30% in relation to the control at a rate 0,5 ml/U and by 10% at a rate of 5 ml/U (fig. 3).

It may be concluded that the use of Albit is effective to improve germination of seeds of sugarbeet
var. Annemaria under lab conditions (dosage 5 ml Albit/U seeds is optimal). Under field conditions,
it was shown that Albit is effective on variety Rosalinda.

‘Attested’ — Official Distributor of Albit LLC
Dipl.Agr.Ing. Manfred Goerke
Project AC ON
www.albit-deutschland.de

Schonebeck (Germany), 31.03.2015

Trial report KWS